The more CAM methods are used, the higher the likelihood of substances interacting with conventional cancer therapies for example via CYP enzymes or P-glycoproteins (Engdal et al. 2009) and causing side effects or physical harm (Wolf et al. 2022). Here, ABCB1 is linked to cancer.